sector medic suppli devic
messag turn solid strength mitg rtg off-set
weak cvg diabet cvg like remain pressur near-
term result sluggish first quarter guidanc organ revenu
growth manag forecast backend load
pipelin begin come focu next month
program start impact meantim trend
growth tap continu see share fairli valu current level
initi outlook mostli line expect manag expect sale grow
constant currenc basi fx expect headwind
impli sale vs consensu come yesterday call
incom statement manag expect grow ebita margin yoy
note howev expect essenti margin
expans come incom line result fx hedg gain pressur
gross margin offset modest sg leverag bottom line ep guidanc
cc slightli better expect street
low end rang previous manag expect top line growth
ex-fx currenc forecast neg impact
individu busi unit compani project cvg segment roughli flat first
quarter headwind weigh busi like repeat
manag expect mitg rtg grow cc next quarter diabet
forecast cc
rais adjust ep estim yoy
previous midpoint manag guidanc rang
model call total revenu cc prior estim
cvg forecast flat growth cardiac rhythm heart failur
cc boost strength coronari structur heart cc
aortic peripher vascular cc mitg expect surgic solut
revenu come cc respiratori gastrointestin renal
ad sale cc meanwhil expect rtg growth pace
strength brain therapi cc pain therapi cc
specialti therapi cc spine cc remain
laggard final expect diabet revenu come cc
full year overal like backend load year mani
headwind weigh busi today either begin resolv
come month anniversari model call growth rebound roughli
first half see figur ep growth ramp sequenti
well
somewhat underwhelm outlook tap expect
continu tri focu investor attent long-term pipelin manag
alloc larg portion commentari call topic
addit opportun ada week plan unveil robot surgeri
platform fall continu see pipelin stori
near-term driver robot high profil launch like micra av much
need refresh compani db implant cardiac monitor product line
unlik move needl much longer term continu see
grower top bottom line respect outlook slightli
large-cap med-tech group averag roughli multipl
gap peer modestli narrow late ntm ep vs
view valuat fair current level given near-term outlook busi
maintain neutral rate
page analyst certif import disclosur
wake covidien merger emerg largest med-tech
compani world boast lead franchis across wide varieti end market
sinc compani work translat unmatch scale competit
advantag includ lead way healthcar landscap shift fee-for-
valu model re-envis mean centuri
devic compani pursu goal deliv econom valu uniqu
combin technolog servic go far beyond tradit purview
med-tech effort mix success date think concept
valu healthcar stay expect fee-for-valu transit play
meantim see execut around compani core financi target
primari driver valu creation front think manag revis
lrp set much achiev bar one could even allow compani deliv
upsid street expect time pipelin matur near-term howev
see stock fairli valu given growth trajectori
share current trade ntm ep estim
ntm ebitda repres discount large-cap med-tech group averag
respect view valuat appropri given medtron
project long-term growth profil top bottom line
respect lag behind broader sector averag better
opportun elsewher group view assign medtron neutral rate
upsid risk rate includ revenu growth exce forecast better-
than-expect execut margin target faster expect shift fee-for-
valu healthcar paradigm benefit compani superior scale play
medtron strength prove disrupt competitor
downsid risk rate includ clinic setback weaker-than-expect adopt
new product caus revenu fall short street estim better-than-expect
share gain competitor failur execut margin expans goal
page analyst certif import disclosur
million usd except
good sold
compani report guggenheim secur llc estim
page analyst certif import disclosur
million usd
compani report guggenheim secur llc estim
page analyst certif import disclosur
